Skip to Main Content

Paper Details

IL-4 receptor blockade is a global repressor of naïve B cell development and responses in a dupilumab-treated patient.
Clin Immunol
6
2022
AD, B cell receptor, B cell subpopulations, CD23, COVID-19, COVID-19 anti-spike, Dupilumab, FCER2, IGHD, IGHD+, IL-4, IL-4 receptor, IL-4R, IL4R, IL4R+IGHD+ nave B cells, atopic dermatitis, genes, memory B cell, nave B cell, nave B cells, patient
Author NameAffiliation
John D MountzDivision of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham
John D MountzDivision of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham
Shanrun LiuDivision of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham
Shanrun LiuDivision of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham
Hui-Chen HsuDivision of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham
Hui-Chen HsuDivision of Clinical Immunology and Rheumatology, The University of Alabama at Birmingham
  • 1 - 6

Datasets

Release 1.2